Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
+2.14M
-
Total reported value, excl. options
-
$150M
-
Value change
-
+$15.9M
-
Number of buys
-
46
-
Number of sells
-
-28
-
Price
-
$8.76
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2017
88 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q4 2017.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 86.6M outstanding shares and own 19.84% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.41M shares), BVF INC/IL (3.23M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), BlackRock Inc. (1.15M shares), FMR LLC (703K shares), Vanguard Group Inc (691K shares), JENNISON ASSOCIATES LLC (531K shares), MILLENNIUM MANAGEMENT LLC (517K shares), ORBIMED ADVISORS LLC (437K shares), and JPMORGAN CHASE & CO (405K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.